Skip to main content
Signal8

Rees Heather

SEC insider (Form 3/4/5 filer). CIK 0001997454. Chief Financial Officer at ATOSSA THERAPEUTICS, INC. (ATOS). 1 reported Form 4/5 transaction since Sep 2024; latest on May 15, 2025. Located in SEATTLE, WA.

Companies Rees Heather has filed insider reports for

  • ATOSSA THERAPEUTICS, INC. (ATOS): Officer, Chief Financial Officer
Rees Heather profile photo

Rees Heather

CIK: 0001997454

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ATOSSA THERAPEUTICS, INC. logo
ATOS

ATOSSA THERAPEUTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ATOSSA THERAPEUTICS, INC. logo
    ATOS

    ATOSSA THERAPEUTICS, INC.

    May 15, 2025
    Award

    Stock Option (right to buy)

    Direct
    543.8K shares-

1-1 of 1